SCHEMBL45162

SCHEMBL45162

CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.88
NR5A2 O00482 1/20 0.88
NR5A1 Q13285 1/20 0.88
MAPT P10636 1/20 0.78
ALDH1A1 P00352 1/20 0.78
FABP3 P05413 1/20 0.70
RECQL P46063 1/20 0.69
ADRA1D P25100 1/20 0.59
PTAFR P25105 1/20 0.59
HTR1D P28221 1/20 0.59
HTR2C P28335 1/20 0.59
ADRA1B P35368 1/20 0.59
DRD3 P35462 1/20 0.59
TMEM97 Q5BJF2 1/20 0.59
PRKCE Q02156 1/20 0.58
PRKCQ Q04759 1/20 0.58
PRKCD Q05655 1/20 0.58
PRKCA P17252 1/20 0.58
SELP P16109 1/20 0.57
ENPP2 Q13822 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159882 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL15709161 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL178155 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL234634 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL23188433 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL235532 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL25354838 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL416515 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL22492184 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1
SCHEMBL1649042 1.00 SMN1; SMN2 (0.88) SMN1; SMN2NR5A2NR5A1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9962 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144803-A1 LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF EDEN OPHTHALMIC PTE LTD. (SG) 2026-05-28 US claimed
EP-4747263-A1 LIPID NANOPARTICLES AND USES THEREOF University of Connecticut (US) 2026-05-27 EP claimed
EP-4746923-A2 DELIVERY SYSTEM COMPRISING LIPID OR POLYMERIC NANOPARTICLES COMPRISING THYROID HORMONES FONDAZIONE RICCARDO TERZI E SILVIO ALBINI (IT) 2026-05-27 EP claimed
CN-122075739-A CircRNA-LNP delivery system for in-vivo induction generation of iTreg, and preparation method and application thereof 2026-05-26 CN claimed
US-12637492-B2 Peptide inhibitors of focal adhesion kinase activity and uses thereof ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2026-05-26 US claimed
CN-122094940-A Ionizable lipids and uses thereof 2026-05-26 CN claimed
CN-122094669-A Nucleic acid delivery compositions 2026-05-26 CN claimed
CN-122094957-A Ionizable lipids and uses thereof 2026-05-26 CN claimed
CN-122071427-A Amino lipid, preparation method and application thereof 中山大学孙逸仙纪念医院 2026-05-22 CN claimed
WO-2026105770-A1 IMMUNOGENIC COMPOSITION COMPRISING LIPID NANOPARTICLES HAVING IMMUNOGENIC PEPTIDE ENCAPSULATED THEREIN 国立大学法人徳島大学 2026-05-21 WO claimed
EP-1260591-A1 High-efficiency assay for protein mannosyl transferases Pharmacia & Upjohn Company (US) 2002-11-27 EP claimed
US-6348453-B1 VIRICIDES FOR ADMINISTERING TO BLOOD, PHOTOSENSITIZERS IN LIPOSOMES NEW YORK BLOOD CENTER, INC. 2002-02-19 US claimed
US-20020019019-A1 Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith GE HEALTHCARE BIO-SCIENCES AB (SE) 2002-02-14 US claimed
EP-0980202-A4 METHODS FOR VIRAL INACTIVATION AND COMPOSITIONS FOR USE IN SAME NEW YORK BLOOD CT INC (US) 2001-03-14 EP claimed
US-6103706-A ADMINISTERING A PHTHALOCYANINE FORMULATED IN A LIPOSOME COMPRISING 1-PALMITOYL-2-OLEOYL-SN-GLYCERO-PHOSPHOCHOLINE AND 1,2-DIOLEOYL-SN-GLYCERO-3-(PHOSPHO-L-SERINE) AND EXPOSING TO LIGHT NEW YORK BLOOD CENTER, INC. (US) 2000-08-15 US claimed
EP-0980202-A1 METHODS FOR VIRAL INACTIVATION AND COMPOSITIONS FOR USE IN SAME THE NEW YORK BLOOD CENTER, INC. (US) 2000-02-23 EP claimed
US-6010890-A PHOTOSENSITIZER IN LIPOSOME CARRIER NEW YORK BLOOD CENTER, INC. (US) 2000-01-04 US claimed
WO-1998048621-A1 METHODS FOR VIRAL INACTIVATION AND COMPOSITIONS FOR USE IN SAME NEW YORK BLOOD CENTER, INC. (US) 1998-11-05 WO claimed
US-5756355-A COMPRISES GOLD RECORDING SURFACE, A FIRST LIPID LAYER CONTAINING TWO PHOSPHOLIPID MOLECULES, EACH LINKED THROUGH LOW CHAIN OXYETHYLENE UNITS TO EACH END OF DISULFIDE GROUP AND ANCHORED TO GOLD SURFACE BY SELF-ASSEMBLY THROUGH SULFUR ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) 1998-05-26 US claimed
EP-0637384-B1 LIPID MEMBRANE SENSORS ECOLE POLYTECH (CH) 1996-10-02 EP claimed